Janux Therapeutics (JANX) Stock Price

$22.72 0.8%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    8
  • Fundamental

    6
  • Technical

    2

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Janux Therapeutics, AI stock picks, stock alerts and much more.

Sign up

JANX AI Stock Analysis

AI stock analysis for JANX is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Janux Therapeutics (JANX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Janux Therapeutics (JANX) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Janux Therapeutics (JANX), currently trading at $22.72, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About JANX

LSE
  • Janux Therapeutics, Inc.

  • Symbol

    JANX

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.3B

Similar Stocks

JANX Alternative Data

Web Traffic

Janux Therapeutics receives an estimated 5508 monthly visitors to januxrx.com.

  • Web Traffic

    5508

  • Change from Previous Month

    4%

  • 3 Month Change

    23.7%

  • YoY Change

    23.7%

Twitter Followers

Janux Therapeutics has 114 Twitter Followers on its main Twitter (also known as X) account, which is up by 3.6% over the last month.

  • Twitter Followers

    114

  • Daily Change

    0%

  • 1 Month Change

    3.6%

  • 3 Month Change

    10.7%

  • YoY Change

    10.7%

LinkedIn Followers

8,816 are following Janux Therapeutics on LinkedIn, up by 3.7% over the last month.

  • LinkedIn Followers

    8816

  • Daily Change

    0.1%

  • 1 Month Change

    3.7%

  • 3 Month Change

    11.8%

Job Postings

Janux Therapeutics has an estimated 7 open job postings, which is down -12.5% over the last month.

  • Job Postings

    7

  • Daily Change

    0%

  • 1 Month Change

    12.5%

  • 3 Month Change

    41.7%

  • YoY Change

    41.7%

LinkedIn Employees

According to LinkedIn, Janux Therapeutics has 99 employees, up by 1% over the last month.

  • LinkedIn Employees

    99

  • Daily Change

    1%

  • 1 Month Change

    1%

  • 3 Month Change

    11.2%

  • YoY Change

    11.2%

Reddit Mentions

Janux Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Janux Therapeutics is 62 out of 100 (bullish).

  • Business Outlook

    62

  • Change from Previous Month

    8.8%

  • 3 Month Change

    19.2%

  • YoY Change

    19.2%

News Mentions

Janux Therapeutics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

JANX Financials

JANX Key Metrics
  • Total Revenue

    $0

  • Net Income

    -$20.2M

  • Earnings per Share

    -$0.36

  • Free cash flow

    -$16.8M

  • EBITDA

    -$28.5M

  • EBITDA Ratio

    0

  • Total Assets

    $1.1B

JANX 2-year Revenue & Income
JANX 2-year Free Cash Flow

JANX Technicals

JANX SMA
JANX RSI

FAQ

What's the current price of Janux Therapeutics (JANX) Stock?
The price of an Janux Therapeutics (JANX) share is $22.72.

What's the market cap of Janux Therapeutics?
The current market cap of Janux Therapeutics is 1.3B.

Should I buy or sell JANX?
Multiple alternative data signals suggest that Janux Therapeutics stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Janux Therapeutics a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Janux Therapeutics stock. The bullish indicators suggest that Janux Therapeutics' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Janux Therapeutics (JANX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Janux Therapeutics stock, given the bullish outlook.

What are some stocks similar to Janux Therapeutics (JANX) that investors often compare it to?
Janux Therapeutics (JANX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Janux Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Janux Therapeutics' stock price to be around $24.43 in 2026. Starting from the current price of $22.72, this represents a 7.5% change in price, indicating a bullish outlook for the stock.

How to buy Janux Therapeutics (JANX) Stock?
Janux Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Janux Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.